Emerging Systemic Treatment Options Across the Spectrum of Breast Cancer Therapy

Join Drs Curigliano and Hurvitz as they discuss advances in systemic treatments for HER2-positive, triple-negative, and HR-positive breast cancer. Credit available for this activity expires: [10/26/22] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/961439?src=mkm_podcast_addon_961439